The potential health and economic impact of dexamethasone treatment for patients with COVID-19

@article{Aguas2020ThePH,
  title={The potential health and economic impact of dexamethasone treatment for patients with COVID-19},
  author={R. Aguas and A. Mahdi and R. Shretta and P. Horby and M. Landray and L. White},
  journal={medRxiv},
  year={2020}
}
Dexamethasone has been shown to reduce mortality in hospitalised COVID-19 patients needing oxygen and ventilation by 18% and 36%, respectively. Here, we estimate the potential number of lives saved and life years gained if this treatment would be rolled out in the UK and globally, as well as its cost-effectiveness of implementing this intervention. We estimate that, for the UK, approximately 12,000 [4,250 - 27,000] lives could be saved by January 2021. Assuming that dexamethasone has a similar… Expand

References

Estimates of the severity of coronavirus disease 2019: a model-based analysis